Approaches for the discovery of new cell-penetrating peptides

被引:25
|
作者
Porosk, Ly [1 ]
Gaidutsik, Ilja [1 ]
Langel, Ulo [2 ]
机构
[1] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia
[2] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden
关键词
CPP; HTS; PTD; delivery vectors; CPP prediction; IN-VITRO; PREDICTION; SEQUENCE; NANOPARTICLES; BRAIN;
D O I
10.1080/17460441.2021.1851187
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The capability of cell-penetrating peptides (CPP), also known as protein transduction domains (PTD), to enter into cells possibly with an attached cargo, makes their application as delivery vectors or as direct therapeutics compelling. They are generally biocompatible, nontoxic, and easy to synthesize and modify. Three decades after the discovery of the first CPPs, similar to 2,000 CPP sequences have been identified, and many more predicted. Nevertheless, the field has a strong commitment to authenticate new, more efficient, and specific CPPs. Areas covered: Although a scattering of CPPs have been found by chance, various systematic approaches have been developed and refined over the years to directly aid the identification and depiction of new peptide-based delivery vectors or therapeutics. Here, the authors give an overview of CPPs, and review various approaches of discovering new ones. An emphasis is placed on in silico methods, as these have advanced rapidly in recent years. Expert opinion: Although there are many known CPPs, there is a need to find more efficient and specific CPPs. Several approaches are used to identify such sequences. The success of these approaches depends on the advancement of others and the successful prediction of CPP sequences relies on experimental data.
引用
收藏
页码:553 / 565
页数:13
相关论文
共 50 条
  • [41] Cell-penetrating peptides in oncologic pharmacotherapy: A review
    Vale, Nuno
    Duarte, Diana
    Silva, Sara
    Correia, Ana Salome
    Costa, Barbara
    Gouveia, Maria Joao
    Ferreira, Abigail
    PHARMACOLOGICAL RESEARCH, 2020, 162
  • [42] Is there a future for cell-penetrating peptides in oligonucleotide delivery?
    Lee, Soo Hyeon
    Castagner, Bastien
    Leroux, Jean-Christophe
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (01) : 5 - 11
  • [43] Photoregulated macrocyclic cell-penetrating peptides (microreview)
    Komarov, Igor V.
    Bakanovych, Iuliia V.
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2020, 56 (06) : 719 - 721
  • [44] CONTROLLING THE ACTIVITY AND SPECIFICITY OF CELL-PENETRATING PEPTIDES
    Bode, S. A.
    Wallbrecher, R.
    Brock, R.
    van Hest, J. C. M.
    Lowik, D. W. P. M.
    JOURNAL OF PEPTIDE SCIENCE, 2014, 20 : S111 - S111
  • [45] Bismuth-Cyclized Cell-Penetrating Peptides
    Ritchey, Jeremy L.
    Filippi, Lindsi
    Ballard, Davis
    Pei, Dehua
    MOLECULAR PHARMACEUTICS, 2024, 21 (10) : 5255 - 5260
  • [46] Cell-Penetrating Peptides for Antiviral Drug Development
    Delcroix, Melaine
    Riley, Lee W.
    PHARMACEUTICALS, 2010, 3 (03): : 448 - 470
  • [47] Studies of cell-penetrating peptides by biophysical methods
    Zorko, Matjaz
    Langel, Ulo
    QUARTERLY REVIEWS OF BIOPHYSICS, 2022, 55
  • [48] Cell-penetrating peptides: strategies for anticancer treatment
    Raucher, Drazen
    Ryu, Jung Su
    TRENDS IN MOLECULAR MEDICINE, 2015, 21 (09) : 560 - 570
  • [49] Cell-penetrating peptides transport therapeutics into cells
    Ramsey, Joshua D.
    Flynn, Nicholas H.
    PHARMACOLOGY & THERAPEUTICS, 2015, 154 : 78 - 86
  • [50] Cell-penetrating peptides and proteins: new inhibitors of allergic airways disease
    Kinyanjui, Margaret W.
    Fixman, Elizabeth D.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2008, 86 (1-2) : 1 - 7